A PEGylated fibroblast growth factor 21 variant improves hepatic steatosis in a mouse model of non-alcoholic steatohepatitis, as determined by magnetic resonance imaging-derived hepatic fat-fraction
Tang, H., Fronheiser, M., Boehm, S., Pena, A., Shorts, A., Zinker, B., Krupinski, J., Malone, H., Chow, P., Charles, E., Du, S., Hayes, W.Volume:
68
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(18)31044-4
Date:
April, 2018
File:
PDF, 99 KB
english, 2018